Beike Biotechnology Co., Ltd.
Beike Biotechnology Co., Ltd., commonly referred to as Beike Biotech, is a leading player in the biotechnology sector, headquartered in China. Established in 2005, the company has made significant strides in regenerative medicine, focusing on innovative cell therapies and advanced medical solutions. With a strong presence in major operational regions across Asia and beyond, Beike Biotech is renowned for its unique offerings, including umbilical cord blood stem cell therapies and personalised treatment plans. These core products stand out due to their commitment to safety and efficacy, positioning the company as a trusted name in the industry. Recognised for its pioneering research and development, Beike Biotech continues to achieve notable milestones, solidifying its market position as a frontrunner in the field of regenerative medicine.
DitchCarbon Score
How does Beike Biotechnology Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Beike Biotechnology Co., Ltd.'s score of 20 is lower than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Beike Biotechnology Co., Ltd.'s reported carbon emissions
Beike Biotechnology Co., Ltd., headquartered in China, currently does not have publicly available carbon emissions data for recent years. As a result, specific figures regarding their emissions in kg CO2e, including Scope 1, 2, or 3 emissions, are not provided. Additionally, there are no documented reduction targets or climate pledges from the company, which suggests a lack of formal commitments to reducing carbon emissions at this time. In the context of the biotechnology industry, companies are increasingly focusing on sustainability and climate action, but Beike Biotechnology Co., Ltd. has yet to outline its strategies or initiatives in this area. As the industry evolves, it will be important for Beike to establish clear climate commitments and reduction targets to align with global sustainability goals.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Beike Biotechnology Co., Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
